Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2; removed the Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-14T19:05:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T15:12:26.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The facility name and location details have been updated, with a specific mention of St. Louis, Missouri, while previous location terms and the older revision number have been removed.
    Difference
    0.8%
    Check dated 2025-08-31T11:48:45.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T02:05:49.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:17:10.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T18:32:52.000Z thumbnail image

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.